Correction to: Trials (2019) 20:49.
https://doi.org/10.1186/s13063-018-3169-3
Following publication of the original article [1], we have been notified that the tagging of one of the author names was done incorrectly in the XML version of the paper. Original and corrected tagging can be seen below.
-
Incorrect name tagging:
Last Name: Pasqua.
First Name: Oscar Della.
-
Correct author name tagging:
Last Name: Della Pasqua.
First Name: Oscar.
Reference
Leeuw, et al. Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials. 2019;20:49. https://doi.org/10.1186/s13063-018-3169-3.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
de Leeuw, T.G., Mangiarini, L., Lundin, R. et al. Correction to: Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial. Trials 20, 368 (2019). https://doi.org/10.1186/s13063-019-3519-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13063-019-3519-9